Literature DB >> 24866022

The effect of Na-selenite treatment on the oxidative stress-antioxidants balance of multiple organ failure.

Gábor Woth1, Bálint Nagy2, Ákos Mérei2, Balázs Ernyey3, Réka Vincze3, Zita Kaurics3, János Lantos4, Lajos Bogár2, Diana Mühl2.   

Abstract

PURPOSE: Our study tested the hypothesis that sodium (Na)-selenite expression treatment can reduce oxidative stress and increase plasma antioxidants, whereas modulating white blood cell antigen expression in severe sepsis. Selenite is a well known cofactor of glutathione peroxidases and other antioxidant enzymes; therefore, one may expect an antioxidant effect of treatment. MATERIALS: We randomized 40 severe septic patients into treatment and control groups. Treatment group (n = 21) received 1000-μg/2 hours Na-selenite load, followed by a 1000-μg/die medication. Oxidative stress markers, including malondialdehyde, maximal free radical production, and plasma antioxidants: free sulfhydryl groups, glutathione levels, and superoxide dismutase and catalase enzyme activity were measured.
RESULTS: According to our results, the treatment regime successfully restored serum selenium levels. Treatment group developed a significant malondialdehyde increase by the fifth study day, whereas reactive oxygen species production decreased significantly. Reduced glutathione and plasma sulfhydryl groups showed no significant difference. Treatment group showed deteriorated expression of CD11a and slight increase of CD49d expression on monocytes throughout our study.
CONCLUSIONS: Although our Na-selenite treatment regime successfully restored the selenium deficiency of severe septic patients, antioxidant and white blood cell antigen expression modulating effect of the therapy was not observed in our patient group.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Selenium; Selenoproteins; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 24866022     DOI: 10.1016/j.jcrc.2014.04.010

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  6 in total

Review 1.  Weaning from veno-venous extracorporeal membrane oxygenation: how I do it.

Authors:  Lars M Broman; Maximilian V Malfertheiner; Andrea Montisci; Federico Pappalardo
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  High-dose intravenous selenium does not improve clinical outcomes in the critically ill: a systematic review and meta-analysis.

Authors:  William Manzanares; Margot Lemieux; Gunnar Elke; Pascal L Langlois; Frank Bloos; Daren K Heyland
Journal:  Crit Care       Date:  2016-10-28       Impact factor: 9.097

3.  The clinical outcomes of selenium supplementation on critically ill patients: A meta-analysis of randomized controlled trials.

Authors:  Yan Zhao; Mengmeng Yang; Zhi Mao; Rui Yuan; Li Wang; Xin Hu; Feihu Zhou; Hongjun Kang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 4.  A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis.

Authors:  Shaojun Li; Tian Tang; Pengfei Guo; Qing Zou; Xiaoxiao Ao; Lan Hu; Liping Tan
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

5.  Oral intake of α‑glucosyl‑hesperidin ameliorates selenite‑induced cataract formation.

Authors:  Yosuke Nakazawa; Miki Aoki; Sho Ishiwa; Naoki Morishita; Shin Endo; Noriaki Nagai; Naoki Yamamoto; Megumi Funakoshi-Tago; Hiroomi Tamura
Journal:  Mol Med Rep       Date:  2020-01-14       Impact factor: 2.952

Review 6.  Selenium and hydrogen selenide: essential micronutrient and the fourth gasotransmitter?

Authors:  Mathun Kuganesan; Kavitej Samra; Eloise Evans; Mervyn Singer; Alex Dyson
Journal:  Intensive Care Med Exp       Date:  2019-12-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.